These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18779994)

  • 1. Palonosetron--a single-dose antiemetic adjunct for hepatic artery radioembolization: a feasibility study.
    Siddiqi NH; Khan AJ; Devlin PM
    Cardiovasc Intervent Radiol; 2009 Jan; 32(1):47-51. PubMed ID: 18779994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States.
    Schwartzberg L; Morrow G; Balu S; Craver C; Gayle J; Cox D
    Curr Med Res Opin; 2011 Aug; 27(8):1613-22. PubMed ID: 21696263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.
    Hajdenberg J; Grote T; Yee L; Arevalo-Araujo R; Latimer LA
    J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: comparison between elderly and non-elderly patient response.
    Massa E; Astara G; Madeddu C; Dessì M; Loi C; Lepori S; Mantovani G
    Crit Rev Oncol Hematol; 2009 Apr; 70(1):83-91. PubMed ID: 18723369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Herrington JD; Jaskiewicz AD; Song J
    Cancer; 2008 May; 112(9):2080-7. PubMed ID: 18327813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting in elderly patients.
    Aapro MS; Macciocchi A; Gridelli C
    J Support Oncol; 2005; 3(5):369-74. PubMed ID: 16218261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palonosetron and dexamethasone for prevention of nausea and vomiting in patients receiving high-dose chemotherapy with auto-SCT.
    Musso M; Scalone R; Crescimanno A; Bonanno V; Polizzi V; Porretto F; Bianchini C; Perrone T
    Bone Marrow Transplant; 2010 Jan; 45(1):123-7. PubMed ID: 19483762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period.
    Kovac AL; Eberhart L; Kotarski J; Clerici G; Apfel C;
    Anesth Analg; 2008 Aug; 107(2):439-44. PubMed ID: 18633021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting.
    Candiotti KA; Kovac AL; Melson TI; Clerici G; Joo Gan T;
    Anesth Analg; 2008 Aug; 107(2):445-51. PubMed ID: 18633022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palonosetron for the prevention of nausea and vomiting in children with acute lymphoblastic leukemia treated with high dose methotrexate.
    Nadaraja S; Mamoudou AD; Thomassen H; Wehner PS; Rosthoej S; Schroeder H
    Pediatr Blood Cancer; 2012 Nov; 59(5):870-3. PubMed ID: 22238187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palonosetron to prevent nausea and vomiting in children undergoing BMT: efficacy and safety.
    Ripaldi M; Parasole R; De Simone G; D'Amico MR; Migliorati R; Zanotta G; Loffredo G; Petruzziello F; Poggi V
    Bone Marrow Transplant; 2010 Nov; 45(11):1663-4. PubMed ID: 20173793
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of weight-adjusted doses of palonosetron for prevention of postoperative nausea and vomiting in day care laparoscopic gynaecological surgery: A dose ranging, randomised controlled trial.
    Jain D; Jain K; Bala I; Gandhi K
    Eur J Anaesthesiol; 2016 Feb; 33(2):104-9. PubMed ID: 26673802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic evaluation and safety profile of a 15-minute versus 30-second infusion of palonosetron in healthy subjects.
    Shah A; DeGroot T; Apseloff G
    J Clin Pharmacol; 2006 Oct; 46(10):1139-45. PubMed ID: 16988202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postembolization syndrome after hepatic transarterial chemoembolization: effect of prophylactic steroids on postprocedure medication requirements.
    Kogut MJ; Chewning RH; Harris WP; Hippe DS; Padia SA
    J Vasc Interv Radiol; 2013 Mar; 24(3):326-31. PubMed ID: 23380736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Achieving optimal antiemetic management].
    Krankenpfl J; 2005; 43(7-10):226-7. PubMed ID: 16515295
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics, metabolism and excretion of intravenous [l4C]-palonosetron in healthy human volunteers.
    Stoltz R; Parisi S; Shah A; Macciocchi A
    Biopharm Drug Dispos; 2004 Nov; 25(8):329-37. PubMed ID: 15378559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation microsphere-induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity.
    Konda A; Savin MA; Cappell MS; Duffy MC
    Gastrointest Endosc; 2009 Sep; 70(3):561-7. PubMed ID: 19577743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omission of day 2 of antiemetic medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: results of a randomized phase III trial.
    Lajolo PP; de Camargo B; del Giglio A
    Am J Clin Oncol; 2009 Feb; 32(1):23-6. PubMed ID: 19194119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy.
    Hamadani M; Awab A; Chaudhary L; Tfayli A
    J Oncol Pharm Pract; 2006 Jun; 12(2):67-8. PubMed ID: 16984743
    [No Abstract]   [Full Text] [Related]  

  • 20. A first report of radioembolization for hepatic metastases from ocular melanoma.
    Kennedy AS; Nutting C; Jakobs T; Cianni R; Notarianni E; Ofer A; Beny A; Dezarn WA
    Cancer Invest; 2009 Jul; 27(6):682-90. PubMed ID: 19219675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.